| Abstrakt: |
Pharmacogenomics (PGx), the study of how an individual's genetic makeup affects their response to medication, is gaining importance in clinical practice. By analyzing patients' genetic profiles, healthcare providers can make more precise and personalized decisions related to medication selection, dosing, and monitoring. This editorial highlights the potential benefits of utilizing PGx to tailor drug interventions, emphasizing the significance of adopting these advancements in clinical practice to enhance patient care. The article also discusses various studies that have investigated the use of PGx in psychiatry, the genetic variability of certain genes in different populations, barriers to implementing PGx testing, and the associations between specific genetic variants and adverse drug reactions. Overall, PGx has the potential to revolutionize how healthcare providers prescribe drugs, leading to more tailored and effective treatment plans for patients. [Extracted from the article] |
